RMC No. 51-2022: Publishes the letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act)

Files
Download this file

Summary

RMC No. 51-2022 publishes the Food and Drug Administration letter endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).

CollapseExpand

Key points

  1. Letter published. The letter is from FDA OIC-Director General Dr. Oscar G. Gutierrez Jr.
  2. Updates to the List. The list includes certain medicines for COVID-19 treatment and hypertension, and it corrects a medicine for cancer.

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.